Recognizing, Diagnosing, and Treating Mitochondrial Diseases: Understanding the Patient Journey – An Interactive Discussion Between Patients/Caregivers and HCPs

LEARNING OBJECTIVES
At the conclusion of this activity, participants will be able to:

• Identify the key clinical findings and presenting symptoms for suspicion of mitochondrial diseases, such as TK2 deficiency
• Summarize the disease burden and key clinical manifestations of mitochondrial diseases across the spectrum of disease severity and age (i.e., early onset vs late onset)
• Utilize genetic testing as part of a diagnostic approach to differentiate mitochondrial diseases from conditions such as spinal muscular atrophy and Pompe disease
• Explain how treatment with dC/dT has impacted the lives of patients/caregivers

TARGET AUDIENCE
The intended audience for this activity neuromuscular specialists and neurologists in specialized centers, community neuromuscular specialists and neurologists, pediatric neurologists, pediatricians, primary care providers, pulmonologists, gastroenterologists, advanced practice providers (NPs, PAs), physical therapists/occupational therapists, nutritionists, genetic counselors, and geneticists.